SLO-BID 300: THEOPHYLLINE EXTENDED-RELEASE CA.
THEOPHYLLINE EXTENDED-RELEASE CA. Key specifications include special_features: ANHYDROUS, features_provided: UNIT DOSE, primary_container_type: STRIP, therapeutic_equivalent: SLO-BID GYROCAP BY RORER PHARM, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, active_medicament_medicinal_strength: 300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-164-8737, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| special_features | ANHYDROUS |
| features_provided | UNIT DOSE |
| primary_container_type | STRIP |
| therapeutic_equivalent | SLO-BID GYROCAP BY RORER PHARM |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| active_medicament_medicinal_strength | 300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT |
| part_name_assigned_by_controlling_agency | THEOPHYLLINE EXTENDED-RELEASE CAPSULES USP 300MG 100S PG |
| capsule_primary_container_content_quantity | 100.000 |
| NSN | 6505-01-164-8737 |
| THERAPEUTIC EQUIVALENT | SLO-BID GYROCAP BY RORER PHARM |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| FEATURES PROVIDED | UNIT DOSE |
| PRIMARY CONTAINER TYPE | STRIP |
| SPECIAL FEATURES | ANHYDROUS |
| CAPSULE PRIMARY CONTAINER CONTENT QUANTITY | 100.000 |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | THEOPHYLLINE EXTENDED-RELEASE CAPSULES USP 300MG 100S PG |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT |